Letter 2 regarding "Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma"
- PMID: 37221834
- PMCID: PMC10366795
- DOI: 10.3350/cmh.2023.0170
Letter 2 regarding "Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma"
Keywords: Carcinoma; ChatGPT; Performance.
Conflict of interest statement
The authors have no conflicts to disclose.
Comment in
-
Correspondence on Letter 2 regarding "Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma".Clin Mol Hepatol. 2023 Jul;29(3):823-824. doi: 10.3350/cmh.2023.0182. Epub 2023 May 31. Clin Mol Hepatol. 2023. PMID: 37254485 Free PMC article. No abstract available.
Comment on
-
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma.Clin Mol Hepatol. 2023 Jul;29(3):721-732. doi: 10.3350/cmh.2023.0089. Epub 2023 Mar 22. Clin Mol Hepatol. 2023. PMID: 36946005 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
